Literature DB >> 16998260

Effect of distal protection device on the microvascular integrity in acute myocardial infarction during primary percutaneous coronary intervention.

Myeong-Ho Yoon1, Seung-Jea Tahk, So-Yeon Choi, Tae-Young Choi, Byoung-Joo Choi, Jung-Hyun Choi, Sang-Yong Yoo, Sung-Gyun Ahn, Zhen-Guo Zheng, Gyo-Seung Hwang, Joon-Han Shin.   

Abstract

BACKGROUND: The use of a distal protection device during primary percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) may preserve the microvascular integrity of the myocardium. METHODS AND
RESULTS: A total of 58 consecutive patients with AMI, who had undergone primary PCI within 24 h after onset, were enrolled (30 patients with the PercuSurge GuardWire System, 28 without). The coronary flow velocity reserve was not different between the 2 groups. In patients with a distal protection device, the post-PCI Thrombolysis In Myocardial Infarction myocardial perfusion grades (TMP) were more favorable (TMP 0/1: 13.3%, TMP 2: 23.3%, TMP 3: 63.4% vs TMP 0/1: 35.7%, TMP 2: 35.7%, TMP 3: 28.6%, p=0.023). These patients also exhibited lower basal and hyperemic microvascular resistance index levels (4.33+/-2.22 vs 5.55+/-2.36 mmHg . cm(-1) . s, p=0.047; 2.39+/-1.40 vs 3.14+/-1.36 mmHg . cm(-1) . s, p=0.045, respectively), and longer basal diastolic deceleration time (679+/-273 vs 519+/-289 ms, p=0.035) after PCI.
CONCLUSION: Distal protection with the PercuSurge GuardWire system may effectively preserve the microvascular integrity of the myocardium during primary PCI in AMI patients.

Entities:  

Mesh:

Year:  2006        PMID: 16998260     DOI: 10.1253/circj.70.1284

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  1 in total

1.  Effect of a distal protection device on epicardial blood flow and myocardial perfusion in primary percutaneous coronary intervention.

Authors:  Bin-quan Zhou; Seung-jea Tahk
Journal:  J Zhejiang Univ Sci B       Date:  2007-08       Impact factor: 3.066

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.